Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Szollosi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacy Practice|April 24, 2023
A questionnaire based survey among pharmacy practitioners to evaluate the level of knowledge and confidence towards antimicrobial stewardshipSyed Wasif Gillani, Manar Khalil Saeed Shahwan, Doreen E Szollosi
Pharmacy Practice|February 16, 2023
A questionnaire based survey among pharmacy practitioners to evaluate the level of knowledge and confidence towards antimicrobial stewardshipSyed Wasif Gillani, Manar Khalil Saeed Shahwan, Doreen E Szollosi
Bioorganic & Medicinal Chemistry|June 16, 2018
Design, synthesis and biological evaluation of piperazino-enaminones as novel suppressants of pro-Inflammatory cytokinesOla M Ghoneim, Ashley Bill, Jyothi Dhuguru, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 1, 2021
The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1βMaitham A Khajah, Sanaa Hawai, Doreen E Szollosi, et al.
Inflammation|September 12, 2016
Novel Piperazino-Enaminones Suppress Pro-Inflammatory Cytokines and Inhibit Chemokine Receptor CCR2Doreen E Szollosi, Ola A M Ghoneim, Mohammed K Manzoor, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseasesDoreen E Szollosi, Mohammed K Manzoor, Andrea Aquilato, et al.
Human Gene Therapy|September 20, 2017
A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse ModelJunjiang Sun, Zhenhua Yuan, Yasmina L Abajas, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacy Practice|April 24, 2023
A questionnaire based survey among pharmacy practitioners to evaluate the level of knowledge and confidence towards antimicrobial stewardshipSyed Wasif Gillani, Manar Khalil Saeed Shahwan, Doreen E Szollosi
Pharmacy Practice|February 16, 2023
A questionnaire based survey among pharmacy practitioners to evaluate the level of knowledge and confidence towards antimicrobial stewardshipSyed Wasif Gillani, Manar Khalil Saeed Shahwan, Doreen E Szollosi
Bioorganic & Medicinal Chemistry|June 16, 2018
Design, synthesis and biological evaluation of piperazino-enaminones as novel suppressants of pro-Inflammatory cytokinesOla M Ghoneim, Ashley Bill, Jyothi Dhuguru, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 1, 2021
The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1βMaitham A Khajah, Sanaa Hawai, Doreen E Szollosi, et al.
Inflammation|September 12, 2016
Novel Piperazino-Enaminones Suppress Pro-Inflammatory Cytokines and Inhibit Chemokine Receptor CCR2Doreen E Szollosi, Ola A M Ghoneim, Mohammed K Manzoor, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseasesDoreen E Szollosi, Mohammed K Manzoor, Andrea Aquilato, et al.
Human Gene Therapy|September 20, 2017
A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse ModelJunjiang Sun, Zhenhua Yuan, Yasmina L Abajas, et al.
Pageof 1